PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · Arq Neuropsiquiatr 2020; 78(05): 255-261
DOI: 10.1590/0004-282X20190177
Article

Increased serum interleukin-9 and interleukin-1β are associated with depression in type 2 diabetes patients

Interleucina-9 e interleucina-1β séricas aumentadas estão associadas à depressão em pacientes com diabetes tipo 2
Prabhat VARSHNEY 
1   Centre for Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi.
,
Rizwana PARVEEN 
2   Department of Pharmaceutical Medicine, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi.
,
Mohd Ashif KHAN 
2   Department of Pharmaceutical Medicine, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi.
,
Sunil KOHLI 
3   Department of Medicine, HIMSR and HAH Centenary Hospital, Jamia Hamdard, New Delhi.
,
Nidhi B. AGARWAL 
1   Centre for Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi.
› Author Affiliations
› Further Information
Also available ateRef
  Permissions and Reprints
Preview

ABSTRACT

Background: Co-morbid diabetes and depression are prevalent chronic conditions negatively affecting quality of life (QoL). Inflammation has been considered as an integral mechanism in patients with both diabetes and depression. Objective: The aim of the present study was to investigate depression and its association with interleukins (IL)-1β and IL-9 in type 2 diabetic patients (T2DM) and controls. The QoL in diabetic patient was also assessed. Methods: Eighty subjects were included, distributed among three groups: Group 1 - Healthy controls; Group 2 - T2DM patients without depression; Group 3 - T2DM patients with depression. Depression and QoL were assessed using Patient Health Questionnaire (PHQ-9) and The Audit of Diabetes-Dependent QoL (ADDQoL), respectively. IL-1β and IL-9 were measured in serum samples of all the patients using ELISA kit. Results: The PHQ score in the Group 3 was significantly higher as compared to Group 1. The ADDQoL scores in the Group 3 were significantly higher as compared to Group 2. Levels of IL-9 and IL-1β were elevated in Group 3, as compared to the other groups. Conclusion: This study showed positive association between depression and IL-1β, IL-9 in T2DM patients. Additionally, the diabetic patients have poorer quality of life, which is further worsened by the presence of depression. Thus, routine assessment for the presence of depression is suggested in T2DM patients.

RESUMO

Introdução: O diabetes e a depressão comórbidas são condições crônicas prevalentes que afetam negativamente a qualidade de vida (QdV). A inflamação tem sido considerada como um mecanismo integral em pacientes com diabetes e depressão. Objetivo: Investigar a depressão e sua associação com interleucinas (IL)-1β e IL-9 em pacientes diabéticos tipo 2 (DM2) e controles. A QdV em diabéticos também foi avaliada. Métodos: Foram incluídos 80 indivíduos, divididos em três grupos: Grupo 1 - controles saudáveis; Grupo 2 - pacientes com DM2 sem depressão; Grupo 3 - pacientes com DM2 com depressão. A depressão e a QdV foram avaliadas usando o Questionário de Saúde do Paciente (Patient Health Questionnaire - PHQ-9) e a auditoria de QdV dependente de diabetes (Audit of Diabetes-Dependent Quality of Life - ADDQoL), respectivamente. IL-1β e IL-9 foram medidas em amostras de soro de todos os pacientes utilizando kit de ELISA. Resultados: O escore do PHQ no grupo 3 foi significativamente maior em comparação ao grupo 1. Os escores de ADDQoL no grupo 3 foram significativamente maiores em comparação ao grupo 2. Os níveis de IL-9 e IL-1β foram elevados no grupo 3, como em comparação com os outros grupos. Conclusão: Este estudo mostrou associação positiva entre depressão e IL-1β, IL-9 em pacientes com DM2. Além disso, os pacientes diabéticos têm pior QdV, o que é ainda piorado pela presença de depressão. Assim, a avaliação rotineira da presença de depressão é sugerida em pacientes com DM2.

Keywords:

Cytokines - Depression - Patient Health Questionnaire

Palavras-chave:

Citocinas - Depressão - Questionário de Saúde do Paciente


Publication History

Received: 25 September 2019

Accepted: 24 October 2019

Article published online:
13 June 2023

© 2020. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Ma Q, Li Y, Wang M, Tang Z, Wang T, Liu C, et al. Progress in metabonomics of type 2 Diabetes Mellitus. Molecules. 2018 Jul;23(7):1834. https://doi.org/10.3390/molecules23071834
  • 2 Lushchak O, Zayachkivska A, Vaiserman A. Metallic nanoantioxidants as potential therapeutics for type 2 diabetes: a hypothetical background and translational perspectives. Oxid Med Cell Longev. 2018 Jun;2018:1-9. https://doi.org/10.1155/2018/3407375
  • 3 Al Mansari A, Obeid Y, Islam N, Fariduddin M, Hassoun A, Djaballah K, et al. GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice. BMJ Open Diabetes Res Care. 2018 Jul;6(1):e000519. https://doi.org/10.1136/bmjdrc-2018-000519
  • 4 Albasheer OB, Mahfouz MS, Solan Y, Khan DA, Muqri MA, Almutairi HA, et al. Depression and related risk factors among patients with type 2 diabetes mellitus, Jazan area, KSA: A cross-sectional study. Diabetes Metab Syndr Clin Res Rev. 2018 Apr;12(2):117-21. https://doi.org/10.1016/j.dsx.2017.09.014
  • 5 Hemmy Asamsama O, Lee JW, Morton KR, Tonstad S. Bidirectional longitudinal study of type 2 diabetes and depression symptoms in black and white church going adults. J Diabetes Metab Disord. 2015 Dec;14(1):25. https://doi.org/10.1186/s40200-015-0150-5
  • 6 Hunter JC, DeVellis BM, Jordan JM, Sue Kirkman M, Linnan LA, Rini C, et al. The association of depression and diabetes across methods, measures, and study contexts. Clin Diabetes Endocrinol. 2018 Dec;4(1). https://doi.org/10.1186/s40842-017-0052-1
  • 7 Talbot F, Nouwen A. A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care. 2000 Oct;23(10):1556-62. https://doi.org/10.2337/diacare.23.10.1556
  • 8 Xia W, Luo Y, Chen Y-C, Zhang D, Bo F, Zhou P, et al. Disrupted functional connectivity of the amygdala is associated with depressive mood in type 2 diabetes patients. J Affect Disord. 2018 Mar;228:207-15. https://doi.org/10.1016/j.jad.2017.12.012
  • 9 Mendenhall E, Norris SA, Shidhaye R, Prabhakaran D. Depression and type 2 diabetes in low- and middle-income countries: A systematic review. Diabetes Res Clin Pract. 2014 Feb;103(2):276-85. https://doi.org/10.1016/j.diabres.2014.01.001
  • 10 Hein M, Lanquart J-P, Loas G, Hubain P, Linkowski P. Prevalence and risk factors of type 2 diabetes in major depression: a study on 703 individuals referred for sleep examinations. psychosomatics. 2018 Mar;59(2):144-57. https://doi.org/10.1016/j.psym.2017.11.003
  • 11 Laake J-PS, Stahl D, Amiel SA, Petrak F, Sherwood RA, Pickup JC, et al. The Association between depressive symptoms and systemic inflammation in people with type 2 diabetes: findings from the South London Diabetes Study. Diabetes Care. 2014 Aug;37(8):2186-92. https://doi.org/10.2337/dc13-2522
  • 12 Herder C, Schmitt A, Budden F, Reimer A, Kulzer B, Roden M, et al. Association between pro- and anti-inflammatory cytokines and depressive symptoms in patients with diabetes-potential differences by diabetes type and depression scores. Transl Psychiatry. 2017 Nov;7(11). https://doi.org/10.1038/s41398-017-0009-2
  • 13 Brigitta B. Pathophysiology of depression and mechanisms of treatment. Dialogues Clin Neurosci. 2002 Mar;4(1):7-20.
  • 14 Habibi L, Tafakhori A, Hadiani R, Maserat-Mashhadi M, Kafrash Z, Torabi S, et al. Molecular changes in obese and depressive patients are similar to neurodegenerative disorders. Iran J Neurol. 2017 Oct;16(4):192-200.
  • 15 Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, Reddy R, Aschner M, Lewis DA, et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry. 2011 Jul;16(7):751-62. https://doi.org/10.1038/mp.2010.52
  • 16 Karlsson L, Nousiainen N, Scheinin NM, Maksimow M, Salmi M, Lehto SM, et al. Cytokine profile and maternal depression and anxiety symptoms in mid-pregnancy-the FinnBrain Birth Cohort Study. Arch Womens Ment Health. 2017 Feb;20(1):39-48. https://doi.org/10.1007/s00737-016-0672-y
  • 17 Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  • 18 Costa FA, Guerreiro JP, Duggan C. An Audit of Diabetes Dependent Quality of Life (ADDQoL) for Portugal: exploring validity and reliability. Pharm Pract (Granada). 2006;4(3):123-8.
  • 19 Sweileh WM, Abu-Hadeed HM, Al-Jabi SW, Zyoud SH. Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine. BMC Public Health. 2014 Dec;14(1):163. https://doi.org/10.1186/1471-2458-14-163
  • 20 van den Biggelaar AHJ, Gussekloo J, de Craen AJM, Frölich M, Stek ML, van der Mast RC, et al. Inflammation and interleukin-1 signaling network contribute to depressive symptoms but not cognitive decline in old age. Exp Gerontol. 2007 Jul;42(7):693-701. https://doi.org/10.1016/j.exger.2007.01.011
  • 21 Tong HV, Luu NK, Son HA, Hoan NV, Hung TT, Velavan TP, et al. Adiponectin and pro-inflammatory cytokines are modulated in Vietnamese patients with type 2 diabetes mellitus. J Diabetes Investig. 2017 May;8(3):295-305. https://doi.org/10.1111/jdi.12579
  • 22 Dembic Z. The Cytokines of the Immune System. The Role of Cytokines in Disease Related to Immune Response. Academic Press: London, UK; 2015. https://doi.org/10.1016/C2013-0-09724-1
  • 23 Li J, Huang S, Huang W, Wang W, Wen G, Gao L, et al. Paeoniflorin ameliorates interferon-alpha-induced neuroinflammation and depressive-like behaviors in mice. Oncotarget. 2017 Jan;8(5):8264-82. https://doi.org/10.18632/oncotarget.14160
  • 24 Menezes Zanoveli J, de Morais H, Caroline da Silva Dias I, Karoline Schreiber A, Pasquini de Souza C, Maria da Cunha J. Depression associated with diabetes: from pathophysiology to treatment. Curr Diabetes Rev. 2016 Jul;12(3):165-78. https://doi.org/10.2174/1573399811666150515125349
  • 25 Derbel CH, Aribi L, Ben Naceur B, Charfeddine F, Abid M, Amami O. Depression in diabetic patients: a comparative study of 100 diabetic patients and 100 controls. Eur Psychiatry. 2015 Mar;30:724. https://doi.org/10.1016/S0924-9338(15)30574-5
  • 26 Goldney RD, Phillips PJ, Fisher LJ, Wilson DH. Diabetes, depression, and quality of life: a population study. Diabetes Care 2004 May;27(5):1066-70. https://doi.org/10.2337/diacare.27.5.1066
  • 27 Derakhshanpour F, Vakili MA, Farsinia M, Mirkarimi K. Depression and quality of life in patients with type 2 diabetes. Iran Red Crescent Med J. 2015 May;17(5):e27676. https://doi.org/10.5812/ircmj.17(5)2015.27676